Kerusso Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.37M Buy
50,385
+9,563
+23% +$1.26M 2.32% 9
2026
Q1
$5.69M Sell
40,822
-2,898
-7% -$406K 2.85% 4
2025
Q4
$5.37M Buy
43,720
+10,421
+31% +$1.27M 2.48% 6
2025
Q3
$3.7M Sell
33,299
-2,022
-6% -$230K 2.27% 14
2025
Q2
$3.92M Buy
35,321
+17
+0% +$1.81K 2.42% 11
2025
Q1
$3.96M Buy
35,304
+895
+3% +$92.3K 2.52% 8
2024
Q4
$3.18M Buy
34,409
+76
+0.2% +$6.84K 2.03% 17
2024
Q3
$2.88M Buy
34,333
+2,068
+6% +$158K 1.83% 26
2024
Q2
$2.21M Buy
+32,265
New +$2.15M 1.61% 34

Other funds holding GILD

Kerusso Capital Management's GILD Position: Q2 2026 in Review

Kerusso Capital Management increased its Gilead Sciences (GILD) stake by 23% in Q2 2026, buying an estimated $1.26M and bringing the position to 50,385 shares worth $6.37M. The position accounts for 2.32% of the portfolio, ranked #9.

Kerusso Capital Management first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Kerusso Capital Management held 50,385 shares of Gilead Sciences worth $6.37M as of Q2 2026.
  • Kerusso Capital Management bought 9,563 Gilead Sciences shares in Q2 2026, an estimated $1.26M.
  • Gilead Sciences made up 2.32% of Kerusso Capital Management's portfolio in Q2 2026, its #9 holding.
  • Kerusso Capital Management first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kerusso Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.